J&J might sell its Ortho Clinical Diagnostics division
Johnson & Johnson might sell its Ortho Clinical Diagnostics business if it can find the right price, CEO Alex Gorsky said Tuesday morning.
J&J might sell its Ortho Clinical Diagnostics division
David Sell
New York - Johnson & Johnson might sell its Ortho Clinical Diagnostics business if it can find the right price, chief executive officer Alex Gorsky said Tuesday morning.
The division has its headquarters in Raritan, N.J., and its research and development center in Rochester, N.Y.
Gorsky said J&J is "initiating the first steps," in the divestiture process of that division.
"When you look at diagnostics, we have good technology and a lot of good businesses, but they are not No. 1 or 2 in the market," Gorsky said.
Gorsky spoke at an investor conference held at the Pierre Hotel to discuss the company's financial results for all of 2012 and the fourth quarter.
A link to Ortho Clinical Diagnostics is here.
- Adolor
- Almac
- AmerisourceBergen
- AstraZeneca
- Auxilium
- Bayer
- Celgene
- Cephalon
- Endo
- GlaxoSmithKline
- Johnson & Johnson
- Kensey Nash
- Lannett
- Merck
- Pfizer
- Roche
- Sanofi-aventis
- Shire
- Stryker
- Synthes
- Teva
- ViroPharma
- West
- Centers for Disease Control and Prevention
- Centers for Medicare and Medicaid
- Clinical Trials
- Food and Drug Administration
- Office of Inspector General, Health and Human Services
- OIG Most-wanted list of fugitives
- Securities and Exchange Commission/Edgar filings
- U.S. Attorney's Office/Eastern Pennsylvania, health-care fraud
- U.S. Department of Health and Human Services
- BIO
- Jersey Association of Medical Equipment Services
- Pennsylvania Association of Medical Suppliers
- Pharmaceutical Research and Manufacturers of America
- Science Center
- American Health Lawyers Association
- Drug and Device Law
- Orange Book blog
- Taxpayers Against Fraud
- Bio Century
- Bio Space
- Cafe Pharma
- Financial Times
- In The Pipeline
- Monday Morning
- New York Times/Prescriptions
- Pharma Live
- Pharma Marketing
- Pharmalot
- The Placebo Effect
- Wall Street Journal/Health blog
